Get 20% lifetime commission for referring investors to digrin.com
here.
ProQR Therapeutics N.V. ( PRQR) - Key Metrics
PRQR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.08 | -$0.08 | -$0.11 | -$0.12 |
| 2026Q1 | $0.02 | -$0.13 | -$0.11 | -$0.11 |
| 2025Q4 | $0.05 | -$0.09 | -$0.13 | -$0.13 |
| 2025Q3 | $0.03 | -$0.10 | -$0.12 | -$0.12 |
| 2025Q2 | $0.04 | -$0.12 | -$0.11 | -$0.11 |
PRQR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.04 |
| 2026Q1 | 0% | -2.70 |
| 2025Q4 | 0% | -5.05 |
| 2025Q3 | 0% | -4.54 |
| 2025Q2 | 0% | -3.61 |
PRQR
Price: $1.31
52 week price:
Earnings Per Share: -0.46 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Netherlands
Volume: 1.0 million
Ebitda: -11.0 millionMarket Capitalization: 172.0 million